Cancer gene therapy - JoVE Visualize

Showing results (1331-1340 of 2,907) with videos related to

Pageof 291

Sort By:

Cancer Gene Therapy|November 21, 1998

Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirusW M Siders, P J Halloran, R G Fenton

Cancer Gene Therapy|November 21, 1998

Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivoJ Xiang, T Moyana

Cancer Gene Therapy|November 21, 1998

Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunityD C Saffran, H M Horton, M A Yankauckas, et al.

Cancer Gene Therapy|March 1, 1997

Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in miceS Yamamoto, S Suzuki, A Hoshino, et al.

Cancer Gene Therapy|March 1, 1997

Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumorsC A Kruse, M D Roper, B K Kleinschmidt-DeMasters, et al.

Cancer Gene Therapy|March 1, 1997

Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma modelD W Ju, X Cao, B Acres

Cancer Gene Therapy|January 1, 1996

Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamideJ Moreb, M Schweder, A Suresh, et al.

Cancer Gene Therapy|October 23, 2019

Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cellsLianna Li, Hao Mei, Abednego Nii Adom Commey

Cancer Gene Therapy|March 18, 2023

MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivoYichao Liang, Di Wu, Qiao Qu, et al.

Cancer Gene Therapy|June 11, 1998

Purine salvage rescue by xanthine-guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase geneS Mineishi, S Nakahara, N Takebe, et al.

Pageof 291

Showing results (1331-1340 of 2,907) with videos related to

Sort By:

Pageof 291

Cancer Gene Therapy|November 21, 1998

Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirusW M Siders, P J Halloran, R G Fenton

Cancer Gene Therapy|November 21, 1998

Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivoJ Xiang, T Moyana

Cancer Gene Therapy|November 21, 1998

Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunityD C Saffran, H M Horton, M A Yankauckas, et al.

Cancer Gene Therapy|March 1, 1997

Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in miceS Yamamoto, S Suzuki, A Hoshino, et al.

Cancer Gene Therapy|March 1, 1997

Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumorsC A Kruse, M D Roper, B K Kleinschmidt-DeMasters, et al.

Cancer Gene Therapy|March 1, 1997

Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma modelD W Ju, X Cao, B Acres

Cancer Gene Therapy|January 1, 1996

Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamideJ Moreb, M Schweder, A Suresh, et al.

Cancer Gene Therapy|October 23, 2019

Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cellsLianna Li, Hao Mei, Abednego Nii Adom Commey

Cancer Gene Therapy|March 18, 2023

MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivoYichao Liang, Di Wu, Qiao Qu, et al.

Cancer Gene Therapy|June 11, 1998

Purine salvage rescue by xanthine-guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase geneS Mineishi, S Nakahara, N Takebe, et al.

Pageof 291